DK1056467T3 - Metode til behandling af sygdomme eller lidelser i det indre øre - Google Patents

Metode til behandling af sygdomme eller lidelser i det indre øre

Info

Publication number
DK1056467T3
DK1056467T3 DK99910259T DK99910259T DK1056467T3 DK 1056467 T3 DK1056467 T3 DK 1056467T3 DK 99910259 T DK99910259 T DK 99910259T DK 99910259 T DK99910259 T DK 99910259T DK 1056467 T3 DK1056467 T3 DK 1056467T3
Authority
DK
Denmark
Prior art keywords
inner ear
sensory cells
disorders
cells
cyclin
Prior art date
Application number
DK99910259T
Other languages
Danish (da)
English (en)
Inventor
Hubert Loewenheim
Original Assignee
Sound Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sound Pharmaceuticals Inc filed Critical Sound Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1056467T3 publication Critical patent/DK1056467T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99910259T 1998-02-23 1999-02-23 Metode til behandling af sygdomme eller lidelser i det indre øre DK1056467T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19807426A DE19807426A1 (de) 1998-02-23 1998-02-23 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
PCT/EP1999/001153 WO1999042088A2 (de) 1998-02-23 1999-02-23 Verfahren zur behandlung von erkrankungen oder störungen des innenohrs

Publications (1)

Publication Number Publication Date
DK1056467T3 true DK1056467T3 (da) 2004-02-09

Family

ID=7858563

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99910259T DK1056467T3 (da) 1998-02-23 1999-02-23 Metode til behandling af sygdomme eller lidelser i det indre øre

Country Status (11)

Country Link
US (1) US7087581B1 (cg-RX-API-DMAC7.html)
EP (1) EP1056467B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002503687A (cg-RX-API-DMAC7.html)
AT (1) ATE250936T1 (cg-RX-API-DMAC7.html)
AU (1) AU763868B2 (cg-RX-API-DMAC7.html)
CA (1) CA2320717C (cg-RX-API-DMAC7.html)
DE (2) DE19807426A1 (cg-RX-API-DMAC7.html)
DK (1) DK1056467T3 (cg-RX-API-DMAC7.html)
ES (1) ES2211055T3 (cg-RX-API-DMAC7.html)
PT (1) PT1056467E (cg-RX-API-DMAC7.html)
WO (1) WO1999042088A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2325198A1 (en) 1999-06-01 2011-05-25 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
EP1307542A2 (en) * 2000-07-11 2003-05-07 Sound Pharmaceuticals Incorporated Stimulation of cellular regeneration and differentiation in the inner ear
AU2003268741B2 (en) 2002-10-02 2009-06-11 Anges Mg, Inc. Drug for auditory dysfunction
DE60323876D1 (de) * 2002-12-17 2008-11-13 Centre Nat Rech Scient Verwendung von purinderivaten zur induktion der differenzierung überzähliger haarzellen und deiter-zellen im entwickelnden corti-organ zur behandlung von taubheit
US8431692B2 (en) * 2008-06-06 2013-04-30 Quark Pharmaceuticals, Inc. Compositions and methods for treatment of ear disorders
DE102010007281A1 (de) 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
RU2480195C1 (ru) * 2011-11-02 2013-04-27 Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава РФ") Способ лечения заболеваний внутреннего уха
EP2802657B1 (en) 2012-01-12 2018-05-02 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
US20150079110A1 (en) * 2012-03-05 2015-03-19 Wake Forest University Health Sciences Regeneration of inner ear cells
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528388A1 (de) 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
AU727037B2 (en) 1995-11-13 2000-11-30 Cenes Pharmaceuticals, Inc. Methods of treating disorders of non-visual sensory epithelia
US5962224A (en) * 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor
WO1998000014A1 (en) * 1996-06-28 1998-01-08 The Regents Of The University Of California Transformation and genetherapy of cells of the inner ear
WO1998013048A1 (en) 1996-09-27 1998-04-02 Trustees Of The University Of Pennsylvania Novel methods for inducing proliferation in auditory receptor epithelium
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product

Also Published As

Publication number Publication date
US7087581B1 (en) 2006-08-08
AU763868B2 (en) 2003-07-31
DE19807426A1 (de) 1999-10-14
CA2320717C (en) 2009-03-24
AU2928199A (en) 1999-09-06
EP1056467A2 (de) 2000-12-06
ATE250936T1 (de) 2003-10-15
ES2211055T3 (es) 2004-07-01
JP2002503687A (ja) 2002-02-05
EP1056467B1 (de) 2003-10-01
DE59907195D1 (de) 2003-11-06
WO1999042088A2 (de) 1999-08-26
PT1056467E (pt) 2004-02-27
CA2320717A1 (en) 1999-08-26
WO1999042088A3 (de) 2000-03-02

Similar Documents

Publication Publication Date Title
PA8478501A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa
NO20000841L (no) N-Aroylfenylalanin-derivater
NO20023085L (no) Ikke-peptidyl inhibitorer av VLA-4 avhengig cellebinding nyttig for behandling av inflammatoriske, autoimmune ogrespiratoriske sykdommer
DE69924641D1 (de) Behandlung von asthma anhand von mek-inhibitoren
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
EP2329842A3 (en) Interleukin-1 inhibitors in the treatment of diseases
DE602004013792D1 (de) Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
ATE495187T1 (de) Dalda-analoge und ihre verwendung
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
NO20021035D0 (no) Fremgangsmåter for anvendelse av rasktvirkende selektive serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon
NO20002702L (no) Tienopyrimidiner
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
ATE250936T1 (de) Verfahren zur behandlung von erkrankungen oder störungen des innenohrs
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
DE60019318D1 (de) Zusammensetzungen und verfahren zur inhibierung vom zellulären g2-übergang und sensitisierung von zellen gegen dna-schädigenden wirkstoffe
ID27545A (id) Penggunaan turunan taksoid baru
ATE460166T1 (de) Chinazolinderivate und ihre verwendung bei der behandlung von thrombocythämie
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
EP2016944A3 (en) Angiogenesis inhibitor containing a derivative of rifampicin
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
NO20055517L (no) 4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung